Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments
(2020) Fundamental and Clinical Pharmacology — Vol. 34, n° 5, p. 530-547 (2020)
Files
fcp125861.pdf
Preprint
Open Access - Adobe PDF
- 19.17 MB
Details
- Authors
Lemaitre, Florian 
Grégoire, Matthieu
- Abstract
- Patients with COVID-19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID-19, either on an outpatient basis or during hospitalization for more severe cases, raises the question of potential drug-drug interactions. Here, we analyzed the potential or proven risk of the co-administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID-19. Practical recommendations are offered, where possible.
- Affiliations
Citations
Lemaitre, F., Solas, C., Grégoire, M., Lagarce, L., Elens, L., Polard, E., Saint‐Salvi, B., Sommet, A., Tod, M., & Barin‐Le Guellec, C. (2020). Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments. Fundamental and Clinical Pharmacology, 34(5), 530-547. https://doi.org/10.1111/fcp.12586 (Original work published 2020)